Track topics on Twitter Track topics that are important to you
LONDON, March 14, 2018/PRNewswire/ -- Report Scope :
This research report categorizes the anti-Parkinson's drugs market by type. Product types include low dopaminergic,
Original Article: Anti-Parkinson's Drugs: Global Markets to 2022NEXT ARTICLE
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...